greeksoup/ stock research
Stock research / United States / STOK / Insiders

Stoke Therapeutics, Inc. insider trading

In twelve months insiders at Stoke Therapeutics bought nothing and sold $8.9M on the open market; 50 of the 83 sales were under plans set months before.

Bought on the open marketNonein twelve months
Sold on the open market$8.9M83 sales
Sales set in advance50 of 83under Rule 10b5-1 plans
Pay taken in stockNone
New to this? How to read this page
  1. Insiders are the people who run the company: officers, directors and owners of 10% or more. They must report a trade on Form 4 within two business days.
  2. A purchase on the open market is the strongest sign: the insider spent their own money.
  3. A sale under a trading plan (Rule 10b5-1) says little: its dates were fixed months before. Sales outside a plan say more, but insiders sell for many reasons, such as taxes or a house.
  4. Grants, option exercises and shares held back for tax are left out.
  5. What is a Form 4? · Form 4 codes

What kind of trades

Insiders only sold: 83 sales worth $8.9M, and 50 of them were under plans set months before, which say little.

Purchasebought with their own money
Pay in stock, own choiceowed cash, chose shares
Sale outside a planthe insider picked the day
Sale under a plandates fixed months before
Says littlecompany plans, board pay, cash units
Bought
none
Sold
33 outside a plan50 under a plan

Every Form 4 line of the last twelve months, counted by kind. The grades come from the filing itself: whether the insider paid cash, whether a plan set the date, whether pay was taken in stock by choice.

Insider trades on the share price

last twelve months

43 marks over twelve months, each in its grade: solid for the stronger signs, hollow or grey for the ones that say little.

PurchasePay in stock, own choiceSale outside a planSale under a planSays little

The blue line is the daily close over twelve months. Each mark is one insider's trades on one day, on that day's price, sized by dollar value. Solid marks are the stronger signs; hollow and grey marks say little. Hover or tap a mark for who, how much and why.

Trades worth a closer look

A purchase stands out when two or more of these hold: a senior insider, several insiders buying within 90 days, a fall of 10% or more in the three months before, or over $1 million. A sale outside a plan is judged the same way. These are the Feed's rules.

Who traded

dollars, twelve months

8 insiders traded. The most: Krainer Adrian R., sale under a plan $3.9M.

One row per insider, sold to the left and bought to the right, split by grade: the paler part of a bar is the part that says little.

How it compares

every company on the site

Open-market sales, twelve months

Open-market purchases, twelve months

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every Form 4 line

    Purchase: bought on the open market with their own moneyTook pay in stock, own choice: owed cash, chose shares instead; a softer signSale: sold on the open market, not under a plan set in advanceSale, trading plan: under a Rule 10b5-1 plan set up months before, so the date was fixed in advanceGrey lines: plan purchases, pay in stock taken by the whole board or under a company plan, and units paid in cash; they say little about the insider's own view
    TradedInsiderRoleTypeSharesPriceValueFiling
    2 October 2026Allan JonathanGeneral Counsel & CORP SECSaletrading plan set in advance · Form 144 notice 2 October 2026627$26.33$16,509Form 4
    1 October 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 3 August 20261,051$26.16$27,494Form 4
    1 September 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 3 August 20263,945$30.51$120,370Form 4
    1 September 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 3 August 20261,600$31.06$49,691Form 4
    18 August 2026Ticho BarryChief Medical OfficerSaleafter a 7% rise over three months · 16% below its one-year high · Form 144 notice 3 August 20264,525$32.01$144,833Form 4
    18 August 2026Ticho BarryChief Medical OfficerSaleafter a 7% rise over three months · 16% below its one-year high · Form 144 notice 3 August 2026242$32.47$7,857Form 4
    18 August 2026Kaye Edward M. MdDirectorSaleafter a 7% rise over three months · 16% below its one-year high11,930$32.01$381,846Form 4
    18 August 2026Kaye Edward M. MdDirectorSaleafter a 7% rise over three months · 16% below its one-year high637$32.47$20,682Form 4
    18 August 2026Allan JonathanGeneral Counsel & CORP SECSaleafter a 7% rise over three months · 16% below its one-year high · Form 144 notice 16 June 20262,716$32.01$86,932Form 4
    18 August 2026Allan JonathanGeneral Counsel & CORP SECSaleafter a 7% rise over three months · 16% below its one-year high · Form 144 notice 16 June 2026145$32.47$4,708Form 4
    3 August 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 3 August 20265,907$28.95$171,008Form 4
    3 August 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 3 August 20261,269$29.45$37,377Form 4
    1 July 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 1 July 20266,728$32.62$219,434Form 4
    1 July 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 1 July 2026500$33.27$16,634Form 4
    16 June 2026Allan JonathanGeneral Counsel & CORP SECSaletrading plan set in advance · Form 144 notice 16 June 20261,457$29.95$43,637Form 4
    1 June 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 1 May 20261,795$30.58$54,891Form 4
    1 May 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 1 May 20262,243$32.79$73,548Form 4
    1 April 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 1 April 20261,838$32.66$60,029Form 4
    20 March 2026Allan JonathanGeneral Counsel & CORP SECSaletrading plan set in advance · Form 144 notice 20 March 20268,692$33.64$292,359Form 4
    20 March 2026Allan JonathanGeneral Counsel & CORP SECSaletrading plan set in advance · Form 144 notice 20 March 2026601$34.41$20,679Form 4
    19 March 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 19 March 20261,461$29.99$43,815Form 4
    18 March 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 19 March 20266,100$31.28$190,831Form 4
    18 March 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 19 March 2026483$31.79$15,354Form 4
    18 March 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 19 March 2026103$32.85$3,384Form 4
    18 March 2026Leggett ThomasChief Financial OfficerSaleafter a 6% fall over three months · 19% below its one-year high2,173$31.28$67,980Form 4
    18 March 2026Leggett ThomasChief Financial OfficerSaleafter a 6% fall over three months · 19% below its one-year high172$31.79$5,468Form 4
    18 March 2026Leggett ThomasChief Financial OfficerSaleafter a 6% fall over three months · 19% below its one-year high37$32.85$1,215Form 4
    18 March 2026Hoitt JasonChief Patient OfficerSaleafter a 6% fall over three months · 19% below its one-year high1,762$31.28$55,122Form 4
    18 March 2026Hoitt JasonChief Patient OfficerSaleafter a 6% fall over three months · 19% below its one-year high139$31.79$4,419Form 4
    18 March 2026Hoitt JasonChief Patient OfficerSaleafter a 6% fall over three months · 19% below its one-year high30$32.85$986Form 4
    18 March 2026Allan JonathanGeneral Counsel & CORP SECSaleafter a 6% fall over three months · 19% below its one-year high4,222$31.28$132,080Form 4
    18 March 2026Allan JonathanGeneral Counsel & CORP SECSaleafter a 6% fall over three months · 19% below its one-year high334$31.79$10,617Form 4
    18 March 2026Allan JonathanGeneral Counsel & CORP SECSaleafter a 6% fall over three months · 19% below its one-year high72$32.85$2,365Form 4
    17 March 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance3,577$32.74$117,109Form 4
    17 March 2026Ticho BarryChief Medical OfficerSaletrading plan set in advance2,587$33.38$86,342Form 4
    17 March 2026Leggett ThomasChief Financial OfficerSaleafter a 2% fall over three months · 14% below its one-year high1,274$32.74$41,710Form 4
    17 March 2026Leggett ThomasChief Financial OfficerSaleafter a 2% fall over three months · 14% below its one-year high922$33.38$30,772Form 4
    17 March 2026Hoitt JasonChief Patient OfficerSaleafter a 2% fall over three months · 14% below its one-year high1,033$32.74$33,820Form 4
    17 March 2026Hoitt JasonChief Patient OfficerSaleafter a 2% fall over three months · 14% below its one-year high748$33.38$24,965Form 4
    17 March 2026Allan JonathanGeneral Counsel & CORP SECSaleafter a 2% fall over three months · 14% below its one-year high2,476$32.74$81,063Form 4
    17 March 2026Allan JonathanGeneral Counsel & CORP SECSaleafter a 2% fall over three months · 14% below its one-year high1,791$33.38$59,775Form 4
    13 March 2026Levin Arthur ADirectorSaletrading plan set in advance · Form 144 notice 13 March 2026605$36.80$22,264Form 4
    10 March 2026Tzianabos ArthurInterim Executive ChairSaletrading plan set in advance · Form 144 notice 10 March 20264,355$40.00$174,214Form 4
    10 March 2026Krainer Adrian R.DirectorSaletrading plan set in advance · Form 144 notice 2 March 202633,243$39.74$1.3 millionForm 4
    2 March 2026Krainer Adrian R.DirectorSaletrading plan set in advance · Form 144 notice 2 March 20267,229$39.66$286,715Form 4
    8 December 2025Allan JonathanGeneral Counsel & CORP SECSaletrading plan set in advance · Form 144 notice 8 December 20251,300$31.60$41,074Form 4
    8 December 2025Allan JonathanGeneral Counsel & CORP SECSaletrading plan set in advance · Form 144 notice 8 December 20252,678$32.61$87,337Form 4
    8 December 2025Kaye Edward M. MdDirectorSaletrading plan set in advance · Form 144 notice 8 December 20253,825$31.44$120,253Form 4
    8 December 2025Kaye Edward M. MdDirectorSaletrading plan set in advance · Form 144 notice 8 December 20258,274$32.52$269,070Form 4
    8 December 2025Kaye Edward M. MdDirectorSaletrading plan set in advance · Form 144 notice 8 December 20251,331$33.10$44,062Form 4
    5 December 2025Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 5 December 20251,673$31.33$52,416Form 4
    5 December 2025Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 5 December 20251,989$31.35$62,346Form 4
    5 December 2025Kaye Edward M. MdDirectorSaletrading plan set in advance · Form 144 notice 5 December 20256,367$31.33$199,481Form 4
    5 December 2025Kaye Edward M. MdDirectorSaletrading plan set in advance · Form 144 notice 5 December 20251,681$31.15$52,358Form 4
    5 December 2025Kaye Edward M. MdDirectorSaletrading plan set in advance · Form 144 notice 5 December 2025500$31.85$15,923Form 4
    5 December 2025Allan JonathanGeneral Counsel & CORP SECSaletrading plan set in advance · Form 144 notice 5 December 20251,004$31.33$31,456Form 4
    5 December 2025Allan JonathanGeneral Counsel & CORP SECSaletrading plan set in advance · Form 144 notice 5 December 20255,437$31.08$168,997Form 4
    5 December 2025Allan JonathanGeneral Counsel & CORP SECSaletrading plan set in advance · Form 144 notice 5 December 20252,344$31.76$74,445Form 4
    4 December 2025Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 5 December 20251,373$30.76$42,238Form 4
    4 December 2025Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 5 December 2025323$31.32$10,115Form 4
    4 December 2025Kaye Edward M. MdDirectorSaletrading plan set in advance · Form 144 notice 5 December 20255,222$30.76$160,647Form 4
    4 December 2025Kaye Edward M. MdDirectorSaletrading plan set in advance · Form 144 notice 5 December 20251,231$31.32$38,550Form 4
    4 December 2025Allan JonathanGeneral Counsel & CORP SECSaletrading plan set in advance · Form 144 notice 5 December 2025824$30.76$25,349Form 4
    4 December 2025Allan JonathanGeneral Counsel & CORP SECSaletrading plan set in advance · Form 144 notice 5 December 2025194$31.32$6,075Form 4
    3 December 2025Ticho BarryChief Medical OfficerSaleafter a 57% rise over three months · 13% below its one-year high · Form 144 notice 3 November 2025789$30.34$23,937Form 4
    3 December 2025Ticho BarryChief Medical OfficerSaleafter a 57% rise over three months · 13% below its one-year high · Form 144 notice 3 November 20251,225$30.85$37,788Form 4
    3 December 2025Kaye Edward M. MdDirectorSaleafter a 57% rise over three months · 13% below its one-year high419$30.34$12,712Form 4
    3 December 2025Kaye Edward M. MdDirectorSaleafter a 57% rise over three months · 13% below its one-year high651$30.85$20,082Form 4
    3 December 2025Allan JonathanGeneral Counsel & CORP SECSaleafter a 57% rise over three months · 13% below its one-year high898$30.34$27,244Form 4
    3 December 2025Allan JonathanGeneral Counsel & CORP SECSaleafter a 57% rise over three months · 13% below its one-year high1,394$30.85$43,002Form 4
    2 December 2025Ticho BarryChief Medical OfficerSaleafter a 52% rise over three months · 16% below its one-year high · Form 144 notice 3 November 20251,244$29.56$36,775Form 4
    2 December 2025Ticho BarryChief Medical OfficerSaleafter a 52% rise over three months · 16% below its one-year high · Form 144 notice 3 November 2025762$30.14$22,968Form 4
    2 December 2025Kaye Edward M. MdDirectorSaleafter a 52% rise over three months · 16% below its one-year high661$29.56$19,540Form 4
    2 December 2025Kaye Edward M. MdDirectorSaleafter a 52% rise over three months · 16% below its one-year high405$30.14$12,207Form 4
    2 December 2025Allan JonathanGeneral Counsel & CORP SECSaleafter a 52% rise over three months · 16% below its one-year high1,416$29.56$41,860Form 4
    2 December 2025Allan JonathanGeneral Counsel & CORP SECSaleafter a 52% rise over three months · 16% below its one-year high868$30.14$26,163Form 4
    24 November 2025Krainer Adrian R.DirectorSaletrading plan set in advance · Form 144 notice 24 November 202540,472$29.72$1.2 millionForm 4
    14 November 2025Krainer Adrian R.DirectorSaletrading plan set in advance · Form 144 notice 14 November 202519,790$26.61$526,693Form 4
    14 November 2025Krainer Adrian R.DirectorSaletrading plan set in advance · Form 144 notice 14 November 202520,682$27.34$565,365Form 4
    3 November 2025Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 3 November 20253,776$25.22$95,247Form 4
    3 November 2025Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 3 November 20251,455$26.02$37,860Form 4
    3 November 2025Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 3 November 2025600$27.54$16,524Form 4
    3 November 2025Ticho BarryChief Medical OfficerSaletrading plan set in advance · Form 144 notice 3 November 2025100$29.35$2,935Form 4
    A filing with several lines appears once per line.
    Read morePay taken in stock by the insider's own choice has the filing's footnote, word for word, in the note under it; for the others, hold the pointer on the type. An award filed at no price shows n/a.